90 % der Glukose wird durch den SGLT-2 Transporter und 10 % durch den vom Glomerulus etwas entfernteren SGLT-1 Transporter wieder aufgenommen
Skillnaden r nnu mer markant fr den nya substansen tirzepatid, dr andelen kvinnliga anvndare (1,3 procent) r mer n dubbelt s hg som den manliga (0,5 procent) under 2025.
From there, they can develop a personalized risk assessment to determine whether non-hormonal options, such as GLP-1 medications, might be appropriate for you
Both medications can support meaningful weight loss when paired with healthy lifestyle habits and medical supervision
Gastrointestinal side effects (flatulence, diarrhoea) may limit tolerability
The peptides themselves only work when administered correctly, and mistakes in preparation or timing can undermine an otherwise well-designed protocol